| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Dec―26 |
COVID-19 and interstitial lung diseases |
N. V. Trushenko, Yu. A. Levina, A. A. Gordeeva, U. V. Panina, F. Z. Babayan, S. N. Avdeev |
| 2 |
[GO] |
2024―Dec―13 |
Analysis of the incidence, disability and mortality rates of the Russian population due to respiratory diseases and COVID-19 in the period 2016 - 2021 |
E. V. Bystritskaya, T. N. Bilichenko, V. M. Misharin |
| 3 |
[GO] |
2024―Dec―13 |
Phagocytic activity of leukocytes in patients with COVID-19 |
M. P. Kostinov, V. V. Gainitdinova, V. V. Osiptsov, I. V. Bisheva, S. A. Skhodova, E. A. Khromova, et al. (+4) I. A. Baranova, N. O. Kryukova, E. S. Sokolova, A. G. Chuchalin |
| 4 |
[GO] |
2024―Dec―12 |
Spectral tussophonobarography as a method for monitoring the effectiveness of cough treatment in patients with COVID-19 |
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, S. N. Feygelman |
| 5 |
[GO] |
2024―Aug―22 |
Invasive pulmonary aspergillosis after COVID-19 |
E. V. Reznik, M. D. Iarovoi, Sh. M. Umakhanova, S. N. Marshala, A. P. Smirnov |
| 6 |
[GO] |
2024―Feb―09 |
Use of inhaled nitric oxide in COVID-19 |
H. C. Nguyen, D. D. Pozdnyakova, I. A. Baranova, A. G. Chuchalin |
| 7 |
[GO] |
2023―Dec―14 |
The macrostructure of lungs on multislice computed tomography scans in the long-term period after COVID-19 pneumonia |
P. M. Kotlyarov, D. G. Soldatov, I. D. Lagkueva, Z. S. Tsallagova, V. A. Solodkiy |
| 8 |
[GO] |
2023―Oct―05 |
Efficacy of olokizumab in patients with mild or moderate COVID-19 and risk factors of progression |
D. S. Fomina, S. S. Andreev, G. V. Andrenova, T. S. Kruglova, D. M. Demidchik, O. S. Kovalevskaya, et al. (+6) Z. Yu. Mutovina, E. A. Dokukina, O. V. Filon, A. V. Petkova, E. K. Khanonina, M. Yu. Samsonov |
| 9 |
[GO] |
2023―Oct―05 |
Dynamics of functional changes in the respiratory system after COVID-19-associated lung injury at one year after hospital discharge |
A. V. Chernyak, M. Kh. Mustafina, Zh. K. Naumenko, E. N. Kalmanova, K. A. Zykov |
| 10 |
[GO] |
2023―Oct―05 |
Fungal infections in patients with progressing COVID-19: pathomorphology and description of clinical cases |
M. V. Mnichovich, A. A. Soldatova, S. I. Usmanov, I. A. Shiripenko, O. A. Sidorova, M. V. Lozina, et al. (+4) S. V. Snegur, Ju. G. Pavlova, P. P. Baklanov, V. M. Kozeev |
| 11 |
[GO] |
2023―Aug―03 |
Mechanisms of pulmonary hypertension development in COVID-19 |
N. A. Tsareva |
| 12 |
[GO] |
2023―Aug―03 |
Impact of early tocilizumab administration on the progression of respiratory failure in COVID-19 patients |
Z. M. Merzhoeva, A. I. Yaroshetskiy, S. A. Savko, A. P. Krasnoshchekova, I. A. Mandel, N. A. Tsareva, et al. (+3) N. V. Trushenko, G. S. Nuralieva, S. N. Avdeev |
| 13 |
[GO] |
2023―Aug―03 |
Assessment of long-term clinical and functional changes in patients recovering from severe COVID-19-associated lung damage |
G. B. Abdullaeva, S. N. Avdeev, E. V. Fominykh, G. S. Gordina, M. Kh. Mustafina |
| 14 |
[GO] |
2023―Feb―12 |
The inspiratory activity of respiratory center and respiratory muscles strength after COVID-19 |
O. I. Savushkina, A. A. Zaicev, E. V Kryukov, P. A Astanin, N. A Aseeva, M. M. Malashenko, O. V. Fesenko |
| 15 |
[GO] |
2023―Feb―12 |
The role of mast cells and their proteases in lung damage associated with COVID-19 |
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, V. V. Shishkina, D. I. Esaulenko, A. A. Filin, et al. (+3) I. A. Savushkina, Inna M. Perveeva, N. G. Alekseeva |
| 16 |
[GO] |
2023―Feb―12 |
On the pathogenesis of destructive pneumonia during COVID-19: a clinical case |
O. V. Zaytseva, E. М. Tolstova, D. V. Khaspekov, N. V. Tkachenko, N. A. Scholohova, H. Yu. Simonovskaya, Т. Yu. Belyaeva |
| 17 |
[GO] |
2023―Feb―12 |
Late complications of the new coronavirus infection: a clinical case |
S. A. Chepurnenko, G. V. Shavkuta, A. A. Demidova |
| 18 |
[GO] |
2022―Dec―30 |
Differential diagnosis of community-acquired pneumonia and lung damage in respiratory viral infections, including COVID-19 |
D. A. Strelkova, A. A. Irgiskin, S. A. Rachina |
| 19 |
[GO] |
2022―Dec―12 |
The clinical course of chronic thromboembolic pulmonary hypertension after COVID-19 |
Z. S. Valieva, M. K. Barkovskaya, A. A. Tkacheva, T. V. Martynyuk |
| 20 |
[GO] |
2022―Dec―12 |
Spectral analysis of cough sounds of patients with COVID-19 |
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, S. N. Feygelman, O. N. Choporov, A. V. Maximov, A. V. Pertsev |
| 21 |
[GO] |
2022―Dec―12 |
Comorbidities in patients with chronic obstructive lung disease and COVID-19 in Almaty (Kazakhstan Republic) |
G. U. Esetova, L. R. Idrisova, S. S. Salimova, B. Konysbay, D. Batyrbay, T. A. Muminov |
| 22 |
[GO] |
2022―Dec―12 |
The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio in prediction of COVID-19 outcome |
L. Suliman, M. Elwasefy, N. S. Farrag, H. A. Tawab, H. W. Abdelwahab |
| 23 |
[GO] |
2022―Oct―11 |
Bacterial ligands in the rehabilitation of healthcare workers after COVID-19 |
N. O. Kryukova, N. D. Abramova, E. A. Khromova, A. A. Khasanova, I. V. Bisheva, S. A. Skhodova, et al. (+4) M. P. Kostinov, I. A. Baranova, O. A. Svitich, A. G. Chuchalin |
| 24 |
[GO] |
2022―Oct―11 |
Chronic obstructive pulmonary disease and COVID-19 |
E. A. Zaryanova, G. L. Osipova, V. V. Osipova |
| 25 |
[GO] |
2022―Oct―11 |
A case of severe COVID-19 in a patient with progressive fibrosing interstitial lung disease |
L. A. Akulkina, M. Yu. Brovko, A. A. Schepalina, V. I. Sholomova, A. A. Kitbalian, A. S. Moiseev, et al. (+2) P. P. Potapov, S. V. Moiseev |
| 26 |
[GO] |
2022―Oct―11 |
Arrangement and objectives of providing patients with lung cancer with treatment during the COVID-19 pandemic in the Russian region |
V. Yu. Startsev, S. V. Golubev |
| 27 |
[GO] |
2022―Oct―11 |
Personalized rehabilitation of patients after COVID-19: the experience of the Republic of Mari El |
R. F. Khamitov, E. A. Soboleva |
| 28 |
[GO] |
2022―Aug―17 |
Results of an open observational multicenter study of the effectiveness and tolerability of levodropropizine in comparison with standard antitussive therapy (real practice) in the treatment of patients with COVID-19 |
A. A. Zaicev, E. V. Bolotova, A. V. Dudnikova, L. V. Sнulzhenko, A. A. Vizel, N. E. Kostina, N. G. Nedashkovskaya |
| 29 |
[GO] |
2022―Aug―17 |
Functional changes in the respiratory system after COVID-19-associated lung injury |
A. V. Chernyak, N. A. Karchevskaya, O. I. Savushkina, M. Kh. Mustafina, E. A. Sinitsyn, E. N. Kalmanova, et al. (+3) M. V. Samsonova, E. A. Zaryanova, K. A. Zykov |
| 30 |
[GO] |
2022―May―02 |
Cough associated with the new coronavirus infection (COVID-19): rational approaches to pharmacotherapy |
S. V. Okovityi, D. S. Sukhanov, A. A. Zaicev |
| 31 |
[GO] |
2022―May―02 |
Asthma and COVID-19 in the elderly: course, survival, predictors of mortality |
V. V. Gaynitdinova, N. N. Avdeev, A. A. Pozdniakova, A. Ye. Vlasenko, I. V. Baytimerova, T. V. Gneusheva |
| 32 |
[GO] |
2022―May―02 |
Approaches to vaccination against the new coronavirus infection in solid organ recipients |
V. B. Polishchuk, M. P. Kostinov, A. A. Ryzhov, N. A. Karchevskaya, E. A. Тarabrin, T. E. Kallagov |
| 33 |
[GO] |
2022―May―02 |
Lipopolysaccharide-binding protein and presepsin in patients with SARS-CoV-2 viral lung disease in the Republic of Crimea |
I. A. Yatskov, V. A. Beloglazov, A. V. Kubyshkin, A. P. Nikolaeva, E. Yu. Zyablitskaya, Ju. E. Kunitskaya, E. N. Lavrenchu |
| 34 |
[GO] |
2021―Dec―17 |
Secretory immunoglobulin A of the respiratory system and COVID-19 |
Nadezhda O. Kryukova, Ekaterina B. Rakunova, M. P. Kostinov, Irina A. Baranova, Oxana A. Svitich |
| 35 |
[GO] |
2021―Dec―17 |
COVID-19 and antibacterial therapy in the inpatient settings: to whom, when, why? |
Nina A. Karoli, Alena V. Aparkina, Elena V. Grigoryeva, Nadezhda A. Magdeeva, Natalia M. Nikitina, Andrey P. Rebrov |
| 36 |
[GO] |
2021―Dec―17 |
Assessment of the effectiveness of medical rehabilitation after COVID-19 based on the functional capacity of the cardiovascular and respiratory systems |
Oksana V. Kamenskaya, Irina Yu. Loginova, Asya S. Klinkova, Alexander M. Chernyavsky, Tatiana A. Bergen, Alexandra R. Tarkova, et al. (+3) Oleg V. Grishin, Michail I. Voevoda, Vladimir V. Lomivorotov |
| 37 |
[GO] |
2021―Oct―20 |
Changes in pulmonary microcirculation after COVID-19 |
Valentina P. Zolotnitskaya, Olga N. Titova, Nataliya A. Kuzubova, Olga V. Amosova, Aleksandra A. Speranskaya |
| 38 |
[GO] |
2021―Oct―20 |
Importance of antiviral H₂S in treatment protocols for COVID-19 |
Ed. J. Van Hezik |
| 39 |
[GO] |
2021―Oct―20 |
Invasive aspergillosis associated with COVID-19 |
Nikolay V. Ovsyannikov, Olga A. Bilevich, Lyudmila A. Zenkova, Olga V. Vasilieva |
| 40 |
[GO] |
2021―Oct―20 |
Long-term pathological changes in lungs after COVID-19 |
Maria V. Samsonova, Andrey S. Kontorschikov, Andrey L. Cherniaev, Kirill Yu. Mikhajlichenko, Liudmila M. Mikhaleva, Oleko D. Mishnev, Oleg V. Zayratyants |
| 41 |
[GO] |
2021―Oct―20 |
Asthma and COVID-19: Аn overview of the guidelines for the management of asthma patients during the COVID-19 pandemic |
Veronika V. Osipova, Galina L. Osipova, Elena A. Zaryanova, Dmitry V. Terekhov |
| 42 |
[GO] |
2021―Oct―20 |
Follow-up pulmonary function of COVID-19 patients 4 months after hospital discharge |
Olga I. Savushkina, Alexander V. Cherniak, Evgeniy V. Kryukov, Nataliya A. Aseeva, Andrey A. Zaytsev |
| 43 |
[GO] |
2021―Oct―20 |
Development of fibrosis and impairment of lung function in patients with a new coronavirus disease |
Igor´ V. Leshchenko, Tatyana V. Glushkova |
| 44 |
[GO] |
2021―Aug―01 |
Thrombosis of the pulmonary arteries branches as a complication of COVID-19 pneumonia (a case report) |
T. I. Kalenchic, S. L. Kabak, N. S. Didenko, I. P. Dulub, A. Yu. Haustovich |
| 45 |
[GO] |
2021―Jun―10 |
Lung damage caused by COVID-19 and community-acquired pneumonia in children: Сomparative clinical and laboratory analysis |
I. V. Leshсhenko, S. A. Tsarkova, M. A. Lapshin, A. M. Aristarkhova |
| 46 |
[GO] |
2021―Jun―10 |
On the prospects for the use of thiamine, pyridoxine, and cyanocobalamin in the complex therapy and rehabilitation of patients with COVID-19 |
O. A. Gromova, I. Yu. Torshin, A. G. Chuchalin |
| 47 |
[GO] |
2021―Jun―10 |
Use of monoclonal antibodies to IL-6 in patients with severe COVID-19 |
S. S. Bobkova, I. N. Tyurin, D. V. Troshchansky, S. N. Avdeikin, D. N. Protsenko |
| 48 |
[GO] |
2021―Jun―10 |
Prevalence of new coronavirus infection COVID-19 in patients undergoing pulmonary thromboendarterectomy (data from a single-center registry) |
I. Yu. Loginova, O. V. Kamenskaya, A. S. Klinkova, V. V. Lomivorotov, A. M. Chernyavsky |
| 49 |
[GO] |
2021―Apr―11 |
Analysis of COVID-19 cases in adult cystic fibrosis patients in Saint-Petersburg and the Leningrad region |
V. R. Makhmutova, T. E. Gembitskaya, A. G. Chermenskiy, O. N. Titova |
| 50 |
[GO] |
2021―Feb―20 |
Diagnosing ventilation inhomogeneity after COVID-19 by multiple-breath nitrogen washout test |
E. V. Kryukov, O. I. Savushkina, A. V. Chernyak, I. C. Kulagina |
| 51 |
[GO] |
2020―Oct―26 |
Immune mechanisms of SARS-CoV-2 and potential drugs in the prevention and treatment of COVID-19 |
M. P. Kostinov, E. V. Markelova, O. A. Svitich, V. B. Polishchuk |
| 52 |
[GO] |
2020―Oct―26 |
Features of pathological anatomy of lungs at COVID-19 |
M. V. Samsonova, A. L. Chernyaev, Zh. R. Omarova, E. A. Pershina, O. D. Mishnev, O. V. Zayratyants, et al. (+7) L. M. Mikhaleva, D. V. Kalinin, V. V. Varyasin, O. A. Tishkevich, S. A. Vinogradov, K. Yu. Mikhaylichenko, A. V. Chernyak |
| 53 |
[GO] |
2020―Oct―26 |
Coagulopathy in COVID-19 |
G. M. Galstyan |
| 54 |
[GO] |
2020―Oct―26 |
Lung ultrasound: the possibilities of diagnosing of lung damage associated with the new coronavirus infection COVID-19 |
G. V. Nekludova, S. N. Avdeev |
| 55 |
[GO] |
2020―Oct―26 |
Non-invasive ventilation in patients with novel coronavirus infection COVID-19 |
Sergey N. Avdeev |
| 56 |
[GO] |
2020―Oct―26 |
Effect of thermal helium-oxygen mixture on viral load in COVID-19 |
L. V. Shogenova, S. D. Varfolomeev, V. I. Bykov, S. B. Tsybenova, A. M. Ryabokon, S. V. Zhuravel, et al. (+5) I. I. Utkina, P. V. Gavrilov, S. S. Petrikov, A. G. Chuchalin, A. A. Panin |
| 57 |
[GO] |
2020―Oct―26 |
Coronavirus disease-2019 (COVID-19): value of IL-6 inhibitors |
E. L. Nasonov |
| 58 |
[GO] |
2020―Oct―26 |
COVID-19 and cardiovascular diseases: from epidemiology to rehabilitation |
M. G. Bubnova, D. M. Aronov |
| 59 |
[GO] |
2020―Oct―26 |
COVID-19 and children |
L. S. Namazova-Baranova, A. A. Baranov |
| 60 |
[GO] |
2020―Oct―26 |
An experience of using Laennec in patients at high risk of a cytokine storm with COVID-19 and hyperferritinemia |
V. A. Maksimov, I. Yu. Torshin, A. G. Chuchalin, L. B. Lazebnik, O. N. Tkacheva, I. D. Strazhesko, O. A. Gromova |
| 61 |
[GO] |
2020―Oct―26 |
Pulmonary rehabilitation of patients with coronavirus infection COVID-19, clinical examples |
N. N. Meshcheryakova, A. S. Belevskiy, A. V. Kuleshov |
| 62 |
[GO] |
2020―Oct―26 |
COVID-19 in cystic fibrosis patients |
E. I. Kondratyeva, S. A. Krasovsky, N. Yu. Kashirskaya, E. L. Amelina, E. K. Zhekaite, V. D. Sherman, et al. (+7) O. I. Simonova, Yu. V. Gorinova, E. V. Boitsova, M. A. Mukhina, I. N. Butyugina, M. A. Makarova, A. B. Malakhov |
| 63 |
[GO] |
2020―Oct―26 |
COVID-19 in individuals adapted to aerobic exercise |
A. Yu. Tret'yakov, S. P. Zakharchenko, L. V. Romasenko, A. V. Dyatlova, A. V. Zhabskaya, O. V. Ermilov, et al. (+2) M. A. Tret'yakov, D. D. Chentsova |
| 64 |
[GO] |
2020―Oct―26 |
An unusual course of COVID-19 infection with late increase in C-reactive protein (clinical case reports) |
S. Yu. Chikina, M. Yu. Brovko, V. V. Royuk, S. N. Avdeev |
| 65 |
[GO] |
2020―Oct―26 |
Imaging of lung pathology in COVID-19 (literature review and own data) |
I. E. Tyurin, A. D. Strutynskaya |
| 66 |
[GO] |
2020―Oct―26 |
Randomized controlled study on pulmonary rehabilitation in COVID-19 patients with pneumonia |
K. V. Lyadov, E. S. Koneva, V. G. Polushkin, E. Yu. Sultanov, M. A. Lukashin |
| 67 |
[GO] |
2020―Oct―26 |
Chronic obstructive lung disease and COVID-19: topical issues |
A. M. Shchikota, I. V. Pogonchenkova, E. A. Turova, M. A. Rassulova, S. A. Gumenyuk |
| 68 |
[GO] |
2020―Oct―26 |
Ultrasound of the lungs as an actual research method in the conditions of a new coronavirus infection SARS-CoV-2 |
E. A. Praskurnichiy, Yu. V. Stefanenkova, M. A. Turaeva |
| 69 |
[GO] |
2020―Oct―26 |
The multispiral computed tomography in the early diagnosis of pneumonia caused by SARS-CoV-2 |
P. M. Kotlyarov, N. I. Sergeev, V. A. Solodkiy, D. G. Soldatov |
| 70 |
[GO] |
2020―Aug―02 |
Dornase alfa in the treatment of COVID-19: destruction of neutrophil extracellular traps |
E. L. Amelina, N. Yu. Kashirskaya, G. V. Shmarina, S. A. Krasovskiy, D. A. Kudlay, O. A. Markova, S. N. Avdeev |
| 71 |
[GO] |
2020―Jun―21 |
Practical guidance for oxygen treatment and respiratory support of patients with COVID-19 infection before admission to intensive care unit |
S. N. Avdeev, N. N. Tsareva, Z. M. Merzhoeva, N. V. Trushenko, A. I. Yaroshetskiy |
| 72 |
[GO] |
2020―Jun―21 |
Comparative analysis of tocilizumab in severe COVID-19-associated pneumonia in patients of different age groups |
D. S. Fomina, N. G. Poteshkina, I. P. Beloglazova, Z. Yu. Mutovina, I. V. Samsonova, E. A. Kovalevskaya, et al. (+10) A. I. Zagrebneva, N. F. Frolova, D. S. Krlikova, T. S. Kruglova, E. N. Bobrikova, S. A. Serdotetskova, O. V. Manchenko, T. N. Markova, A. A. Chernov, M. A. Lysenko |
| 73 |
[GO] |
2020―Feb―28 |
The prevention, diagnosis and treatment of the new coronavirus infection 2019-nCoV. Temporary guidelines Ministry of Health of the Russian Federation |
Article Editorial |
